C E
GLP-1RA Dosage in Patients with Overweight or Obesity Wegovy (semaglutide) is the only GLP-1RA with established CV benefit and can be initiated at 0.25 mg (once weekly
For people with prediabetes, this can mean returning to normal glycemic status
Foundayo removes those restrictions: you can take it anytime, with or without food, and no fasting window is required
But they work in totally different ways: Sermorelin therapy: stimulates the pituitary gland to release growth hormone, which increases IGF-1 and supports bone, muscle, and metabolic function Estrogen therapy: binds to estrogen receptors rather than growth hormone receptors, impacting many of the same tissues, including bones, muscles, and fat As women balance the symptoms that arise during perimenopause and midlife, finding the right solution varies based on personal needs, body type, and other health factors
Rather, they provide context that allows your provider to make more evidence-based dosing and product recommendations
